HEADER TRANSFERASE 08-NOV-12 3ZBF TITLE STRUCTURE OF HUMAN ROS1 KINASE DOMAIN IN COMPLEX WITH CRIZOTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 1934-2232; COMPND 5 SYNONYM: PROTO-ONCOGENE C-ROS, PROTO-ONCOGENE C-ROS-1, RECEPTOR COMPND 6 TYROSINE KINASE C-ROS ONCOGENE 1, C-ROS RECEPTOR TYROSINE KINASE; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS TRANSFERASE, TYROSINE KINASE EXPDTA X-RAY DIFFRACTION AUTHOR M.MCTIGUE,Y.DENG,W.LIU,A.BROOUN,A.STEWART REVDAT 5 20-DEC-23 3ZBF 1 REMARK REVDAT 4 08-MAY-19 3ZBF 1 REMARK REVDAT 3 24-APR-19 3ZBF 1 SOURCE REVDAT 2 03-JUL-13 3ZBF 1 JRNL REVDAT 1 12-JUN-13 3ZBF 0 JRNL AUTH M.M.AWAD,R.KATAYAMA,M.MCTIGUE,W.LIU,Y.DENG,A.BROOUN, JRNL AUTH 2 L.FRIBOULET,D.HUANG,M.D.FALK,S.TIMOFEEVSKI,K.D.WILNER, JRNL AUTH 3 E.L.LOCKERMAN,T.M.KHAN,S.MAHMOOD,J.F.GAINOR,S.R.DIGUMARTHY, JRNL AUTH 4 J.R.STONE,M.MINO-KENUDSON,J.G.CHRISTENSEN,J.IAFRATE, JRNL AUTH 5 J.A.ENGELMAN,A.T.SHAW JRNL TITL ACQUIRED RESISTANCE TO CRIZOTINIB FROM A MUTATION IN JRNL TITL 2 CD74-ROS1 JRNL REF N.ENGL.J.MED. V. 368 2395 2013 JRNL REFN ISSN 0028-4793 JRNL PMID 23724914 JRNL DOI 10.1056/NEJMOA1215530 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 328539.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 16486 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.236 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 796 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2360 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2330 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 816 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0100 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 16863 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2480 REMARK 3 BIN R VALUE (WORKING SET) : 0.2730 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 126 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2260 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 137 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.63000 REMARK 3 B22 (A**2) : -1.63000 REMARK 3 B33 (A**2) : 3.26000 REMARK 3 B12 (A**2) : 2.53000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.35 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.670 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.630 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.660 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.240 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.220 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 77.91 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : UNL.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : UNL.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3ZBF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-NOV-12. REMARK 100 THE DEPOSITION ID IS D_1290054757. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAY-12 REMARK 200 TEMPERATURE (KELVIN) : 87 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18796 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.120 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.880 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 31.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.59000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PDB ENTRY 2XP2 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE OBTAINED BY THE HANGING REMARK 280 DROP VAPOR DIFFUSION METHOD AT 13 DEGREES C BY MIXING 1.5 REMARK 280 MICROLITERS OF SOLUTION CONTAINING A 1:3 MOLAR RATIO OF REMARK 280 PHOSPHORYLATED ROS1 KD (12.2MG/ML) TO CRIZOTINIB AND 1.5 REMARK 280 MICROLITERS OF RESERVOIR SOLUTION CONTAINING 25% (W/V) PEG 3350, REMARK 280 0.6M POTASSIUM THIOCYANATE AND 0.1M SODIUM CITRATE TRIBASIC REMARK 280 DIHYDRATE, PH5.6. CRYSTALS WERE FLASH-FROZEN IN LIQUID NITROGEN REMARK 280 AFTER TRANSFER TO 2 MICROLITERS OF RESERVOIR SOLUTION CONTAINING REMARK 280 25% (V/V) GLYCEROL AS A CRYOPROTECTANT., VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 16.78567 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.57133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 16.78567 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.57133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1911 REMARK 465 ALA A 1912 REMARK 465 HIS A 1913 REMARK 465 HIS A 1914 REMARK 465 HIS A 1915 REMARK 465 HIS A 1916 REMARK 465 HIS A 1917 REMARK 465 HIS A 1918 REMARK 465 ASP A 1919 REMARK 465 TYR A 1920 REMARK 465 GLY A 1921 REMARK 465 ILE A 1922 REMARK 465 PRO A 1923 REMARK 465 THR A 1924 REMARK 465 THR A 1925 REMARK 465 GLU A 1926 REMARK 465 ASN A 1927 REMARK 465 LEU A 1928 REMARK 465 TYR A 1929 REMARK 465 PHE A 1930 REMARK 465 GLN A 1931 REMARK 465 GLY A 1932 REMARK 465 SER A 1933 REMARK 465 GLY A 1954 REMARK 465 ALA A 1955 REMARK 465 PHE A 1956 REMARK 465 LYS A 2111 REMARK 465 ASN A 2112 REMARK 465 ASP A 2113 REMARK 465 TYR A 2114 REMARK 465 TYR A 2115 REMARK 465 ARG A 2116 REMARK 465 LYS A 2117 REMARK 465 ARG A 2118 REMARK 465 GLY A 2119 REMARK 465 GLU A 2120 REMARK 465 GLY A 2121 REMARK 465 LEU A 2122 REMARK 465 ASP A 2231 REMARK 465 GLU A 2232 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A2230 CA C O CB CG CD NE REMARK 470 ARG A2230 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1948 -83.67 -146.77 REMARK 500 GLU A1958 117.18 164.99 REMARK 500 ASP A1966 72.87 51.22 REMARK 500 ASP A2079 32.67 -160.65 REMARK 500 ALA A2081 145.69 176.58 REMARK 500 THR A2176 -12.81 -48.95 REMARK 500 LYS A2228 52.89 -101.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A3008 DISTANCE = 6.29 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VGH A 3000 DBREF 3ZBF A 1934 2232 UNP P08922 ROS1_HUMAN 1934 2232 SEQADV 3ZBF MET A 1911 UNP P08922 EXPRESSION TAG SEQADV 3ZBF ALA A 1912 UNP P08922 EXPRESSION TAG SEQADV 3ZBF HIS A 1913 UNP P08922 EXPRESSION TAG SEQADV 3ZBF HIS A 1914 UNP P08922 EXPRESSION TAG SEQADV 3ZBF HIS A 1915 UNP P08922 EXPRESSION TAG SEQADV 3ZBF HIS A 1916 UNP P08922 EXPRESSION TAG SEQADV 3ZBF HIS A 1917 UNP P08922 EXPRESSION TAG SEQADV 3ZBF HIS A 1918 UNP P08922 EXPRESSION TAG SEQADV 3ZBF ASP A 1919 UNP P08922 EXPRESSION TAG SEQADV 3ZBF TYR A 1920 UNP P08922 EXPRESSION TAG SEQADV 3ZBF GLY A 1921 UNP P08922 EXPRESSION TAG SEQADV 3ZBF ILE A 1922 UNP P08922 EXPRESSION TAG SEQADV 3ZBF PRO A 1923 UNP P08922 EXPRESSION TAG SEQADV 3ZBF THR A 1924 UNP P08922 EXPRESSION TAG SEQADV 3ZBF THR A 1925 UNP P08922 EXPRESSION TAG SEQADV 3ZBF GLU A 1926 UNP P08922 EXPRESSION TAG SEQADV 3ZBF ASN A 1927 UNP P08922 EXPRESSION TAG SEQADV 3ZBF LEU A 1928 UNP P08922 EXPRESSION TAG SEQADV 3ZBF TYR A 1929 UNP P08922 EXPRESSION TAG SEQADV 3ZBF PHE A 1930 UNP P08922 EXPRESSION TAG SEQADV 3ZBF GLN A 1931 UNP P08922 EXPRESSION TAG SEQADV 3ZBF GLY A 1932 UNP P08922 EXPRESSION TAG SEQADV 3ZBF SER A 1933 UNP P08922 EXPRESSION TAG SEQRES 1 A 322 MET ALA HIS HIS HIS HIS HIS HIS ASP TYR GLY ILE PRO SEQRES 2 A 322 THR THR GLU ASN LEU TYR PHE GLN GLY SER ILE GLU ASN SEQRES 3 A 322 LEU PRO ALA PHE PRO ARG GLU LYS LEU THR LEU ARG LEU SEQRES 4 A 322 LEU LEU GLY SER GLY ALA PHE GLY GLU VAL TYR GLU GLY SEQRES 5 A 322 THR ALA VAL ASP ILE LEU GLY VAL GLY SER GLY GLU ILE SEQRES 6 A 322 LYS VAL ALA VAL LYS THR LEU LYS LYS GLY SER THR ASP SEQRES 7 A 322 GLN GLU LYS ILE GLU PHE LEU LYS GLU ALA HIS LEU MET SEQRES 8 A 322 SER LYS PHE ASN HIS PRO ASN ILE LEU LYS GLN LEU GLY SEQRES 9 A 322 VAL CYS LEU LEU ASN GLU PRO GLN TYR ILE ILE LEU GLU SEQRES 10 A 322 LEU MET GLU GLY GLY ASP LEU LEU THR TYR LEU ARG LYS SEQRES 11 A 322 ALA ARG MET ALA THR PHE TYR GLY PRO LEU LEU THR LEU SEQRES 12 A 322 VAL ASP LEU VAL ASP LEU CYS VAL ASP ILE SER LYS GLY SEQRES 13 A 322 CYS VAL TYR LEU GLU ARG MET HIS PHE ILE HIS ARG ASP SEQRES 14 A 322 LEU ALA ALA ARG ASN CYS LEU VAL SER VAL LYS ASP TYR SEQRES 15 A 322 THR SER PRO ARG ILE VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 16 A 322 ALA ARG ASP ILE TYR LYS ASN ASP TYR TYR ARG LYS ARG SEQRES 17 A 322 GLY GLU GLY LEU LEU PRO VAL ARG TRP MET ALA PRO GLU SEQRES 18 A 322 SER LEU MET ASP GLY ILE PHE THR THR GLN SER ASP VAL SEQRES 19 A 322 TRP SER PHE GLY ILE LEU ILE TRP GLU ILE LEU THR LEU SEQRES 20 A 322 GLY HIS GLN PRO TYR PRO ALA HIS SER ASN LEU ASP VAL SEQRES 21 A 322 LEU ASN TYR VAL GLN THR GLY GLY ARG LEU GLU PRO PRO SEQRES 22 A 322 ARG ASN CYS PRO ASP ASP LEU TRP ASN LEU MET THR GLN SEQRES 23 A 322 CYS TRP ALA GLN GLU PRO ASP GLN ARG PRO THR PHE HIS SEQRES 24 A 322 ARG ILE GLN ASP GLN LEU GLN LEU PHE ARG ASN PHE PHE SEQRES 25 A 322 LEU ASN SER ILE TYR LYS SER ARG ASP GLU HET VGH A3000 30 HETNAM VGH 3-[(1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-(1- HETNAM 2 VGH PIPERIDIN-4-YL-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE HETSYN VGH CRIZOTINIB FORMUL 2 VGH C21 H22 CL2 F N5 O FORMUL 3 HOH *137(H2 O) HELIX 1 1 PRO A 1941 GLU A 1943 5 3 HELIX 2 2 THR A 1987 LYS A 2003 1 17 HELIX 3 3 ASP A 2033 ALA A 2044 1 12 HELIX 4 4 THR A 2052 MET A 2073 1 22 HELIX 5 5 ALA A 2081 ARG A 2083 5 3 HELIX 6 6 PRO A 2124 MET A 2128 5 5 HELIX 7 7 ALA A 2129 GLY A 2136 1 8 HELIX 8 8 THR A 2139 THR A 2156 1 18 HELIX 9 9 SER A 2166 THR A 2176 1 11 HELIX 10 10 PRO A 2187 TRP A 2198 1 12 HELIX 11 11 GLU A 2201 ARG A 2205 5 5 HELIX 12 12 THR A 2207 LYS A 2228 1 22 SHEET 1 AA 5 LEU A1945 GLY A1952 0 SHEET 2 AA 5 VAL A1959 VAL A1965 -1 O VAL A1959 N LEU A1951 SHEET 3 AA 5 GLU A1974 THR A1981 -1 O ILE A1975 N ALA A1964 SHEET 4 AA 5 TYR A2023 GLU A2027 -1 O ILE A2024 N LYS A1980 SHEET 5 AA 5 GLN A2012 CYS A2016 -1 N LEU A2013 O ILE A2025 SHEET 1 AB 2 PHE A2075 ILE A2076 0 SHEET 2 AB 2 ARG A2107 ASP A2108 -1 O ARG A2107 N ILE A2076 SHEET 1 AC 2 CYS A2085 VAL A2087 0 SHEET 2 AC 2 VAL A2098 ILE A2100 -1 O LYS A2099 N LEU A2086 CISPEP 1 GLU A 2020 PRO A 2021 0 3.11 CISPEP 2 LEU A 2123 PRO A 2124 0 -23.79 SITE 1 AC1 11 ALA A1978 LEU A2010 GLU A2027 MET A2029 SITE 2 AC1 11 GLY A2032 ASP A2033 ARG A2083 ASN A2084 SITE 3 AC1 11 LEU A2086 GLY A2101 ASP A2102 CRYST1 106.854 106.854 50.357 90.00 90.00 120.00 P 64 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009359 0.005403 0.000000 0.00000 SCALE2 0.000000 0.010806 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019858 0.00000